세계의 치료용 BCG 백신 시장 보고서(2023년)

“Therapeutic BCG Vaccines Global Market Report 2023 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on therapeutic bcg vaccines market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for therapeutic bcg vaccines? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The therapeutic bcg vaccines market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Type: Therapy BCG; Immune BCG

• 2) By Demographics: Pediatrics; Adults

• 3) By End Use: Hospitals; Clinics; Other End Users

• Companies Mentioned: Merck & Co., Inc.; Sanofi Pasteur; Japan BCG Laboratory; China National Biotec Group; Serum Institute of India Pvt. Ltd.

• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA

• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

• Time series: Five years historic and ten years forecast.

• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

• Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Major players in the therapeutic BCG vaccines market are Merck & Co., Inc., Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute of India Pvt. Ltd., InterVax Ltd., GreenSignal Bio Pharma Limited, Statens Serum Institute, AJ Vaccines, BB-NCIPD Ltd., Biomed Lublin S.A., PowderJect Pharmaceuticals, Microgen, Taj Pharma Ltd. and BioFarma.

The global therapeutic BCG vaccines market is expected to grow from $50.73 billion in 2022 to $53.18 billion in 2023 at a compound annual growth rate (CAGR) of 4.82%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The therapeutic BCG vaccines market is expected to grow to $65.62 billion in 2027 at a CAGR of 5.40%.

The therapeutic BCG vaccines market consists of sales of vectors, peptides, proteins, DNA, and dendritic cells. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

Therapeutic BCG vaccine refers to a vaccine that offers defense against TB, also referred to as tuberculosis. The therapeutic BCG vaccine, which stands for the Bacillus Calmette-Guerin vaccine, is not a part of the standard NHS vaccination schedule. Only one dose of the BCG vaccine should be administered in a lifetime.

Asia-Pacific was the largest region in the therapeutic BCG vaccines market in 2022. The regions covered in this report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The two major types of therapeutic BCG vaccines are therapy BCG and immune BCG. Therapy BCG refers to a kind of intravesical immunotherapy that aids the immune system's destruction of cancer cells and is frequently used to treat bladder cancer in its early stages. By demographics, BCG vaccines can be used on pediatrics and adults. These are used by several end-users, such as hospitals, clinics, and other end-users.

The rising number of tuberculosis (TB) cases worldwide will propel the growth of the therapeutic BCG vaccine market going forward. Tuberculosis (TB) is an infectious illness that can be potentially dangerous and primarily impacts the lungs. People can contract tuberculosis from one another by coughing or sneezing small droplets of bacteria into the air. BCG vaccines are used to stimulate the immune system to fight infection but do not cause TB since the germs are weak. It consistently offers protection against the most dangerous types of TB, like adolescent TB meningitis. The BCG vaccine protects against tuberculosis which helps to fight against infection, hence the usage of therapeutic BCG vaccines increased. For instance, in October 2022, according to a report published by the World Health Organization, a specialized agency of the United Nations responsible for international public health, 10.6 million people were predicted to have contracted tuberculosis (TB) in 2021, an increase of 4.5% from 2020, and 1.6 million died from TB (including 187,000 HIV-positive individuals). Therefore, the rising number of tuberculosis (TB) cases worldwide is driving the growth of the therapeutic BCG vaccine market.

Strategic partnerships have emerged as a key trend gaining popularity in the therapeutic BCG vaccine market. Major companies operating in the therapeutic BCG vaccine market are focused on collaborating with other key players to sustain their position in the market. For instance, in July 2021, Zendal, a Spain-based pharmaceutical company, partnered with a US-based not-for-profit organization to advance the tuberculosis vaccine candidate MTBVAC into efficacy trials. The only live, attenuated Mycobacterium tuberculosis vaccine currently being developed is MTBVAC. It is now being developed to prevent tuberculosis in adults and adolescents, for whom there is currently no effective vaccination, and as a more potent and potentially long-lasting vaccine than BCG for infants. This statement coincides with the rapid development of several vaccinations to guard against COVID-19.

In February 2022, Sanofi S.A., a France-based multinational pharmaceutical and healthcare company, acquired Amunix for an undisclosed amount. This acquisition provides access to Amunix Pro-XTEN, XPAT, and XPAC technology to deliver conditionally activated biologics of the next generation. The technology platform supports Sanofi's efforts to accelerate and expand its contributions to cutting-edge therapies for oncology patients, with about 20 compounds presently in development. It is a perfect addition to Sanofi's existing R&D platforms. Amunix is a US-based immuno-oncology company intended to discover, design, and develop novel biologics, proteins, and peptide therapeutics.

The countries covered in the therapeutic BCG vaccines market report are: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The therapeutic BCG vaccines market research report is one of a series of new reports from The Business Research Company that provides therapeutic BCG vaccines market statistics, including therapeutic BCG vaccines industry global market size, regional shares, competitors with a therapeutic BCG vaccines market share, detailed therapeutic BCG vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic BCG vaccines industry. This therapeutic BCG vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Table of Contents

1. Executive Summary

2. Therapeutic BCG Vaccines Market Characteristics

3. Therapeutic BCG Vaccines Market Trends And Strategies

4. Therapeutic BCG Vaccines Market - Macro Economic Scenario

• 4.1. COVID-19 Impact On Therapeutic BCG Vaccines Market
• 4.2. Ukraine-Russia War Impact On Therapeutic BCG Vaccines Market
• 4.3. Impact Of High Inflation On Therapeutic BCG Vaccines Market

5. Therapeutic BCG Vaccines Market Size And Growth

• 5.1. Global Therapeutic BCG Vaccines Historic Market, 2017-2022, $ Billion
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints On The Market
• 5.2. Global Therapeutic BCG Vaccines Forecast Market, 2022-2027F, 2032F, $ Billion
  • 5.2.1. Drivers Of The Market
  • 5.2.2. Restraints On the Market

6. Therapeutic BCG Vaccines Market Segmentation

• 6.1. Global Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Therapy BCG
• Immune BCG
• 6.2. Global Therapeutic BCG Vaccines Market, Segmentation By Demographics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Pediatrics
• Adults
• 6.3. Global Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• Hospitals
• Clinics
• Other End Users

7. Therapeutic BCG Vaccines Market Regional And Country Analysis

• 7.1. Global Therapeutic BCG Vaccines Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 7.2. Global Therapeutic BCG Vaccines Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

8. Asia-Pacific Therapeutic BCG Vaccines Market

• 8.1. Asia-Pacific Therapeutic BCG Vaccines Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 8.3. Asia-Pacific Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

9. China Therapeutic BCG Vaccines Market

• 9.1. China Therapeutic BCG Vaccines Market Overview
• 9.2. China Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion
• 9.3. China Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

10. India Therapeutic BCG Vaccines Market

• 10.1. India Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 10.2. India Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

11. Japan Therapeutic BCG Vaccines Market

• 11.1. Japan Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 11.2. Japan Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

12. Australia Therapeutic BCG Vaccines Market

• 12.1. Australia Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 12.2. Australia Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

13. Indonesia Therapeutic BCG Vaccines Market

• 13.1. Indonesia Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 13.2. Indonesia Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

14. South Korea Therapeutic BCG Vaccines Market

• 14.1. South Korea Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 14.2. South Korea Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

15. Western Europe Therapeutic BCG Vaccines Market

• 15.1. Western Europe Therapeutic BCG Vaccines Market Overview
• 15.2. Western Europe Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 15.3. Western Europe Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

16. UK Therapeutic BCG Vaccines Market

• 16.1. UK Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 16.2. UK Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

17. Germany Therapeutic BCG Vaccines Market

• 17.1. Germany Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 17.2. Germany Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

18. France Therapeutic BCG Vaccines Market

• 18.1. France Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 18.2. France Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

19. Eastern Europe Therapeutic BCG Vaccines Market

• 19.1. Eastern Europe Therapeutic BCG Vaccines Market Overview
• 19.2. Eastern Europe Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 19.3. Eastern Europe Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

20. Russia Therapeutic BCG Vaccines Market

• 20.1. Russia Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 20.2. Russia Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

21. North America Therapeutic BCG Vaccines Market

• 21.1. North America Therapeutic BCG Vaccines Market Overview
• 21.2. North America Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 21.3. North America Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

22. USA Therapeutic BCG Vaccines Market

• 22.1. USA Therapeutic BCG Vaccines Market Overview
• 22.2. USA Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 22.3. USA Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

23. South America Therapeutic BCG Vaccines Market

• 23.1. South America Therapeutic BCG Vaccines Market Overview
• 23.2. South America Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 23.3. South America Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

24. Brazil Therapeutic BCG Vaccines Market

• 24.1. Brazil Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 24.2. Brazil Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

25. Middle East Therapeutic BCG Vaccines Market

• 25.1. Middle East Therapeutic BCG Vaccines Market Overview
• 25.2. Middle East Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 25.3. Middle East Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

26. Africa Therapeutic BCG Vaccines Market

• 26.1. Africa Therapeutic BCG Vaccines Market Overview
• 26.2. Africa Therapeutic BCG Vaccines Market, Segmentation By Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
• 26.3. Africa Therapeutic BCG Vaccines Market, Segmentation By End Use, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

27. Therapeutic BCG Vaccines Market Competitive Landscape And Company Profiles

• 27.1. Therapeutic BCG Vaccines Market Competitive Landscape
• 27.2. Therapeutic BCG Vaccines Market Company Profiles
  • 27.2.1. Merck & Co. Inc.
    • 27.2.1.1. Overview
    • 27.2.1.2. Products and Services
    • 27.2.1.3. Strategy
    • 27.2.1.4. Financial Performance
  • 27.2.2. Sanofi Pasteur
    • 27.2.2.1. Overview
    • 27.2.2.2. Products and Services
    • 27.2.2.3. Strategy
    • 27.2.2.4. Financial Performance
  • 27.2.3. Japan BCG Laboratory
    • 27.2.3.1. Overview
    • 27.2.3.2. Products and Services
    • 27.2.3.3. Strategy
    • 27.2.3.4. Financial Performance
  • 27.2.4. China National Biotec Group
    • 27.2.4.1. Overview
    • 27.2.4.2. Products and Services
    • 27.2.4.3. Strategy
    • 27.2.4.4. Financial Performance
  • 27.2.5. Serum Institute of India Pvt. Ltd.
    • 27.2.5.1. Overview
    • 27.2.5.2. Products and Services
    • 27.2.5.3. Strategy
    • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Therapeutic BCG Vaccines Market

29. Therapeutic BCG Vaccines Market Future Outlook and Potential Analysis

30. Appendix

• 30.1. Abbreviations
• 30.2. Currencies
• 30.3. Historic And Forecast Inflation Rates
• 30.4. Research Inquiries
• 30.5. The Business Research Company
• 30.6. Copyright And Disclaimer